United Therapeutics Corporation
USD539.33
-5.59 (-1.03%)
CEO
Martine A. Rothblatt
IPO Date
1999-06-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$547.42
Prev. Close
$544.92
Day Low
$535.63
Day High
$552.46
52W Low
$272.12
52W High
$609.35
Market Cap
$22.89B
Volume
0.25M
| 13.3 |
| 31 Dec 2023 | FY | 88.9% | 42.3% | 16.5% | 13.7% | 0.12 | 4.41 | 10.4 |
| 31 Dec 2022 | FY | 92.4% | 37.6% | 15.2% | 12.0% | 0.17 | 9.85 | 17.4 |
| 31 Dec 2021 | FY | 92.7% | 28.2% | 12.0% | 9.2% | 0.20 | 7.61 | 20.4 |
| 31 Dec 2020 | FY | 92.7% | 34.7% | 15.2% | 11.2% | 0.24 | 6.70 | 13.0 |
| 31 Dec 2019 | FY | 91.9% | -7.2% | -3.8% | -2.7% | 0.31 | 4.03 | -36.9 |
| 31 Dec 2018 | FY | 87.8% | 36.2% | 21.1% | 17.3% | 0.09 | 6.39 | 8.0 |
| 31 Dec 2017 | FY | 93.9% | 24.2% | 19.9% | 14.5% | 0.12 | 3.26 | 15.6 |
| 31 Dec 2016 | FY | 95.5% | 44.6% | 38.3% | 30.7% | 0.00 | 4.29 | 8.8 |
| 14.8 |
| 30 Sept 2025 | Q3 | 87.4% | 42.4% | 5.1% | 4.6% | 0.00 | 6.40 | 13.6 |
| 30 Jun 2025 | Q2 | 89.0% | 38.8% | 4.3% | 3.9% | 0.00 | 7.26 | 10.5 |
| 31 Mar 2025 | Q1 | 88.4% | 40.6% | 4.7% | 4.2% | 0.03 | 5.46 | 10.7 |
| 31 Dec 2024 | Q4 | 89.7% | 40.9% | 4.7% | 4.1% | 0.05 | 5.25 | 13.2 |
| 30 Sept 2024 | Q3 | 88.9% | 41.3% | 5.1% | 4.3% | 0.07 | 4.58 | 12.9 |
| 30 Jun 2024 | Q2 | 89.1% | 38.9% | 4.9% | 4.1% | 0.09 | 4.35 | 12.7 |
| 31 Mar 2024 | Q1 | 89.2% | 45.2% | 5.7% | 4.7% | 0.11 | 3.77 | 8.7 |
| 31 Dec 2023 | Q4 | 88.4% | 35.3% | 3.6% | 3.0% | 0.12 | 4.41 | 11.9 |